Abstract
In Emilia Romagna region 77,6% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 51 cases of cervicocarcinoma and 22 related deaths and thus results to be cost-effective (29.903€/QALY). When the vaccination programme is extended to 16-year-old girls a further 47 cancer cases and 20 deaths could be prevented, with a very similar cost-effectiveness ratio. In Emilia Romagna region, the net cost for woman vaccinated is 177€ for the single cohort and 180€ for the multiple cohort.
Cite
CITATION STYLE
Cavallo, M. C., Cipriani, F., Gerzeli, S., Demarteau, N., Marocco, A., & Bamfi, F. (2008). Emilia Romagna. Farmeconomia. Health Economics and Therapeutic Pathways, 9(1S), 43–45. https://doi.org/10.7175/fe.v9i1s.1007
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
